Study on Visual Function Impairments in Dry Age-related Macular Degeneration
Launched by DUKE UNIVERSITY · Mar 28, 2013
Trial Information
Current as of April 28, 2025
Completed
Keywords
ClinConnect Summary
This prospective, exploratory study will be performed in multiple arms:
A. Arm 1: a pilot study of up to 40 patients (30 patients with dry age-related macular degeneration and 10 normal age-matched controls) in order to test 1) the feasibility of performing the visual function tests in this population and 2) test/retest reliability over 1-2 months. If the pilot study reveals that the visual function tests proposed are feasible and have high reliability, the larger study (Phase 2) will be subsequently performed.
B. Arm 2: a study of up to 160 patients (130 dry AMD patients and 32 controls)...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Capable and willing to provide consent
- • 2. Has been diagnosed with dry age-related macular degeneration stages 1-3
- • 3. At least 50 years of age
- Exclusion Criteria:
- • 1. Unable or unwilling to give consent
- • 2. Under 50 years of age
- • 3. Presence of retinal pathology such as central geographic atrophy, hemorrhage or retinal fluid, and other macular pathology other than AMD
- • 4. Presence of dense cataracts in the study eye(s) that can affect visual function tests
- • 5. Presence of glaucoma requiring treatment during the study and/or visual field defects
- • 6. Presence retinal laser or surgical theraphy in study eye (s)
- • 7. Any of other ocular condition requiring long-term theraphy or surgery during the study
- • 8. Participant has photographically significant corneal or media opacities in either eye that would preclude adequate ophthalmic imaging and functional testing
- • 9. Diagnosis of nystagmus that will interfere with testing
- • 10. High myopia -8 Diopters or more severe
- • 11. Participant has, in the opinion of the Investigator, any physical or mental condition that would increase the risk of participation in the stduy or may interfere with the study procedures, evaluations and outcome assessments.
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Eleonora Lad, MD, PhD
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials